ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a development stage biopharmaceutical company. It is engaged in the discovery and development of pharmaceutical products for the treatment of cancer that have not been successfully treated with conventional therapeutics.

Note: This is not a U.S. company, but they cross-list their shares on a U.S. stock exchange - see the related symbol CT:ONC.

$2.11
As of 10/26/2021     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Canada
Country of incorporation:  
IPO date:  08/26/2013
Outstanding shares:  54,959,672
Average volume:  203,242
Market cap:   $123,109,665
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
CUSIP:    682310107
ISIN:        
Sedol:      
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   2.57
PS ratio:   0.00
Return on equity:   -64.01%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy